Krempa David sold ETON
August 24, 2026 · Form 4 insider transaction
Krempa David sold 25,000 shares of Eton Pharmaceuticals, Inc. at $65.07 per share, a transaction worth $1.63M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
25,000
Price
$65.07
Total value
$1.63M
InsiderKrempa David
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 24, 2026
Filing dateAugust 24, 2026
Shares owned after37,025
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.; The shares were sold in multiple trades at prices ranging from $64.88 to $65.57. The price reported above reflects the weighted average sales price.